Important Vaccine Safety Project Video To Watch - 8 minutes

https://m.youtube.com/watch?v=pFTLzmIciZM&feature=youtu.be

Please watch this important eight minute video. The "Vaccine Safety Project" is hosted by Robert F. Kennedy Jr. Who is with the newly formed Children's Health Defense organization.

This is a current presentation about vaccine safety and its history, including how the FDA approvals actually work regarding vaccines and how there are truly no current safety studies showing vaccines can do more good, than harm.

Please share this video in social media and with friends and family who are not informed, confused or questioning vaccines for their children and families.

__,_._,___

Very important new research on Homeopathie about the Remedy Rhus Tox!

Perhaps the most important research on homeopathic medicine was just published at the website of the most respected scientific journal in the world -"Nature".

This vitally important group of studies have conclusively shown that homeopathic doses of Rhus toxicodendron (poison ivy) are significantly more effective than placebo in the treatment of neuropathy in rats.  

Further, this research tested various doses of Rhux toxicodebndron.  Each potency, including 30X, was found to have PROFOUND measurable effects on neuropathy.  

Still further, this research shows that this homeopathic medicine had much of the same similar benefits as a conventional drug, Gabapentin but was found to be safer. 

There are presently over 300 clinical trials published in peer reivew medical journals, most of which show the efficacy of homeopathic treatment.  

This new study confirms that homeopathic medicine, what Dana Ullman calls "the original nanomedicine," have both biological effects and clinical efficacy.   

Read more here! https://www.nature.com/articles/s41598-018-31971-9__,_._,___

Newborn screening for autism: in search of candidate biomarkers.

This study points to as a marker for autism:

"GST [Glutathione S-transferase] is a metabolic biomarker directly associated with ASD. The human gene product for GST constitutes a candidate susceptibility protein due to its tissue distribution and role in oxidative stress and methionine metabolism, which results in neuronal injury and death."

Read study here: Newborn Screening for Autism: In search of candidate biomarkers.

https://www.ncbi.nlm.nih.gov/m/pubmed/23547820/

Biomark Med. 2013 Apr;7(2):247-60. doi: 10.2217/bmm.12.108.

Mizejewski GJ1, Lindau-Shepard B, Pass KA.

Division of Translational Medicine, Wadsworth Center, NYS Department of Health, PO Box 509, Albany, NY 12201 0509, USA.

Abstract
BACKGROUND:
Autism spectrum disorder (ASD) represents a wide range of neurodevelopmental disorders characterized by impairments in social interaction, language, communication and range of interests. Autism is usually diagnosed in children 3-5 years of age using behavioral characteristics; thus, diagnosis shortly after birth would be beneficial for early initiation of treatment.

AIM:
This retrospective study sought to identify newborns at risk for ASD utilizing bloodspot specimens in an immunoassay.

MATERIALS & METHODS:
The present study utilized stored frozen specimens from ASD children already diagnosed at 15-36 months of age. The newborn specimens and controls were analyzed by immunoassay in a multiplex system that included 90 serum biomarkers and subjected to statisical analysis.

RESULTS:
Three sets of five biomarkers associated with ASD were found that differed from control groups. The 15 candidate biomarkers were then discussed regarding their association with ASD.

CONCLUSION:
This study determined that a statistically selected panel of 15 biomarkers successfully discriminated presumptive newborns at risk for ASD from those of nonaffected controls.

Exerpt:

"GST [Glutathione S-transferase] is a metabolic biomarker directly associated with ASD. The human gene product for GST constitutes a candidate susceptibility protein due to its tissue distribution and role in oxidative stress and methionine metabolism, which results in neuronal injury and death."

 

Important: FDA and Homeopathy - Please make your comments in support now at https://homeopathychoice.org/

Please share this petition with friends and family!

Please go now to the Homeopathy Choice website for easy-to-follow instructions on how you can help support the petition AND save homeopathy in the U.S. (Scroll down to the BIG red button).

 

We need at least a thousand unique comments sent to the FDA. _________________________________________________________________________________________________________________

Our FDA petition seeks to protect homeopathy including non-HPUS remedies while we work toward a legislative solution.

The petition is a first line of defense that forces FDA to slow down and respond.

BY PAOLA BROWN, PRESIDENT, AMERICANS FOR HOMEOPATHY CHOICE 

August 30, 2018 

We at Americans for Homeopathy Choice are a consumer group made up mostly of mothers who use homeopathy as the first line of health promotion for our families. This July we filed a Citizen Petition with the FDA as a first step in protecting consumer access to homeopathy including non-HPUS remedies.  In our ongoing effort to be transparent with the homeopathy community, we’d like to provide additional insight into our petition.

First, we support and are working towards developing broader legislation to advance homeopathy.  This is a vital part of an overall strategy to protect homeopathy, and we invite all to collaborate with us in this effort. We also believe that filing a petition with the FDA strengthens this legislative strategy. In our view, developing a legislative strategy alone without a petition in place leaves homeopathy vulnerable. 

In offering an alternative to the FDA’s Draft Guidance on Drug Products Labeled as Homeopathic (issued December 2017), our petition seeks to maintain the status quo in which homeopathy is governed by the HPUS and quality and purity in the manufacture of homeopathic remedies is appropriately safeguarded through the FDA’s Compliance Policy Guide (CPG) 400.400.  

The petition directly addresses the FDA’s Draft Guidance which proposes to eliminate CPG 400.400. The new guidance would establish a precedent that all remedies in the HPUS would technically be illegal unless they undergo the same approval process as pharmaceuticals.  One estimate for this approval process puts the cost for a single remedy at more than $3 million. This is an immediate danger to the availability of current homeopathic remedies within the HPUS.

Given the stakes, to wait for a legislative solution could be fatal to the future of homeopathy in America. In any battle, you must first protect the home front, and that’s exactly what our Citizen Petition accomplishes. It forces the FDA to respond to all issues we list before it can legally begin to enforce any portion of the agency’s Draft Guidance.

The FDA assured us in one of our meetings that it would be prudent in selecting which remedies it chooses to target, promising that the vast majority of homeopathic remedies will remain available. We have a hard time taking the FDA at its word when the agency is at the same time proposing to violate the law by shifting already approved homeopathic remedies listed in the HPUS into the unapproved category. Leaving this FDA threat unaddressed without a counter-proposal would place homeopathy in a defenseless position.  

In addition, the FDA currently has three anti-homeopathy petitions on its docket.  Without our petition, all FDA’s regulatory energy would be directed towards petitions that are clearly trying to limit homeopathy. Our petition has shifted the playing field, requiring the FDA to put energy towards policies that support homeopathy.  

Our petition is the product of collaboration with practitioners, homeopathy-related organizations, manufacturers, consumers and others. We also used valuable insights gleaned from in-person meetings with the FDA.

Here’s what the petition asks for:

We request the CPG 400.400 be converted into a regulation. This would accomplish two priorities:  First, we would remove the FDA’s discretionary relationship with the CPG 400.400 so that it would be unable to modify or replace it, as currently proposed by the FDA’s Draft Guidance. Second, forcing the FDA to adhere to guidelines in the CPG 400.400 as a regulation sends a bold message: We are limiting the FDA’s authority and requiring compliance with the Food, Drug and Cosmetic Act.

This is intentional. Bold requests like this get the attention of Congress. In order to advance our larger legislative agenda, we must have congressional attention. We object to an intrusive FDA that places over burdensome regulations on industry and commerce. However, we recognize that the CPG 400.400 has created a healthy and fair framework for FDA enforcement of the existing manufacturing and marketing guidelines for homeopathy over the past 30 years; in many ways it also places important restrictions on what the FDA can do.

We share the concern that there are thousands of important homeopathic remedies that are currently being used, but which are not actually listed in the HPUS.  First, know that the CPG 400.400 makes provision for these non-HPUS remedies saying that non-HPUS homeopathic medicines can be manufactured if documentation is provided.

Second, while this provision is useful, we are fully aware of the critical need to include all these homeopathic medicines within the HPUS and will direct our broader legislative strategy to accomplish this objective.  Again, the FDA’s proposed Draft Guidance will define all homeopathic medicines as technically illegal.

Failing to file the petition would have left the homeopathy community open to actions that could devastate the homeopathy industry long before a legislative solution is achieved. We plan to continue working to create strong legislation to protect homeopathy while also pursuing our petition with the FDA.

If you have not read our petition yet, please read it.  We welcome all comments from individuals or groups that are constructive.  The FDA has opened a comment docket for our petition and we encourage you to file your comments.  Like the FDA, we read each comment and use that feedback to inform our overall strategy.

As mothers, we aren’t afraid to act boldly when necessary, putting words and promises into action. And, we aren’t afraid of taking on the FDA.  Since we formed in January of this year, we have:

·         -personally visited over 100 congressional offices.

·         -had in-person appointments with over a dozen congressional representatives.

·         -been the only homeopathy organization in the United States to hold in-person meetings with the FDA regarding the Draft Guidance on homeopathy, including continued dialogue.

·         -submitted over 62 pages of legal arguments and documents to the FDA.

·         -produced dozens of videos, keeping our members and followers informed with frequent updates.

·         -continuously managed over 100 volunteer moms who are taking action to protect homeopathy.

We seek at all times to keep the homeopathy community united. We believe that we will only succeed as a community if we stick together. The key to our unity is consultation and collaboration that leads to consensus and then action. But, successful collaboration can only be based on accurate and complete information which is why we are circulating this piece to the homeopathy community.

We invite you to collaborate with us and to communicate your ideas and concerns. We look forward to working with all of you in the homeopathy community to reach a solution that will protect homeopathy for the long term.

1.      Compliance Policy Guide, sec. 400.400 under “LABELING” reads: “Documentation must be provided to support that those products or ingredients which are not recognized officially in the HPUS, an addendum to it, or its supplements are generally recognized as homeopathic products or ingredients.”https://www.fda.gov/iceci/compliancemanuals/compliancepolicyguidancemanual/ucm074360.htm

 

 

Testimonial: Birth Control Pill Detoxification Over 12 Weeks by Mom, Age 36

Birth Control Pill Detoxification Over 12 Weeks by Mom, Age 36
www.homeopathyforwomen.org/testimonials.htm

"From January 2004 to January 2011, I took the birth control pill.  By mid-2007, migraines, constant sinus pressure, acid reflux, and insomnia were the norm.  I attributed these to the stress of law school/practice.  After stopping the birth control pill I felt better, but the aforementioned ailments remained.

In July 2011, we learned we were pregnant.  Much prayer and tears over our autistic son led us to the blessing who is Kari J. Kindem.  Not only did Kari initiate a holistic healing process for our joy of a boy, she cleaned up my exhausted, birth control poisoned body through detox.  

Since the birth of our son, I've experienced recurrent sore throats, ongoing sinus pressure and headaches, migraines, severe left jaw pain, left shoulder/arm/hand pain with the loss of some fine motor skills in the hand, chronic fatigue, and anxiety.  Menses were scanty and painful.  Sleep was intermittent.  I sweated profusely - and sometimes it smelled quite unladylike.  Skin was dull.  Allergies to food and cosmetics were skyrocketing.  A mental fog kept me bogged down.  Everything felt overwhelming.  I told myself this was all from the stress of our son's difficulties.  Kari explained that these ill effects were the birth control pill still wreaking internal havoc.  

The 10 week birth control detox changed my life:  No more migraines, no more chronic sinus pressure, a healthy GI system, regular menses, deep sleep, drastically less and infrequent joint pain, mental clarity, and no more fatigue - but plenty of energy.  The tell-tale sign the detox is working is the reliving of symptoms, but for a short time - and sometimes the last.  Around one month into the detox, I had a HTMA hair test performed and began the prescribed supplements and diet.  This turbo-boosted my well-being.  And, hello, bright skin and some weight loss.  

I didn't realize how horribly I felt on a daily basis until this detox eliminated the perpetual aches, exhaustion, and general malaise.  Today's energy level reminds me more of how I felt in high school - which was great.  

My husband has never known me without chronic stress, migraines, and fatigue.  My son has never had a mother not riddled with anxiety, joint pain, and the drain of constant sinus issues.  Now, they have someone more joyful, affectionate, patient, and engaged.  Our lives are much happier.  We thank God every day for Kari J. Kindem and her amazing, life-changing practice."

Mother and Attorney, Alabama, USA, August 201

 

_,___

Sign petition to support Vaccine Attorney Alan Phillips

The North Carolina State Bar wants to investigate Vaccine attorney Alan Phillips, J.D. 

Alan is the author of one of the best guides for parents who are dealing with mandatory vaccine state laws, The Authoritative Guide To Vaccine Legal Exemptions. His book has helped thousands of parents better understand how they can navigate draconian immunization laws in their home states. 

But now, he's under fire from the state of North Carolina where they are moving to remove his ability to practice law. This is his life, this is how he feeds his family, this is the way he helps parents everywhere deal with the stress of confusing vaccine laws.

Please help by signing the Change.org petition and buying a copy of his top-selling book. 

Sign the petition here 

Buy The Authoritative Guide To Vaccine Legal Exemptions 

 

March 20, 2018

https://worldmercuryproject.org/news/molecular-mimicry-understanding-the-link-between-vaccines-and-autoimmune-disease/?utm_source=mailchimp

Molecular Mimicry—Understanding the Link between Vaccines and Autoimmune Disease

By the World Mercury Project Team

Autoimmune diseases have become increasingly common in the United States and other high-income countries over the past several decades and now affect an estimated 5%-10% of the population in those countries. The broad category of “autoimmune disease” comprises over 100 different rheumatic, endocrinological, gastrointestinal and neurological conditions that ensue when the body’s immune responses get misdirected against itself. Researchers generally agree that environmental factors (including drugs and chemicals) are strongly to blame for the rise in autoimmune disorders, possibly in conjunction with genetic and epigenetic influences—and studies dating back to the mid-1990s indicate that vaccines, with their unique configuration of viral or bacterial antigens and adjuvants, are a biologically plausible trigger.

The pathogenic hallmark of autoimmune disease is the production of proteins called autoantibodies, whereby the immune system mistakenly attacks the body’s own organs, tissues and cells instead of fighting external pathogens. Vaccines can prompt autoantibody production through a mechanism called “molecular mimicry.” As explained by Israeli researchers in a new review article in Cellular & Molecular Immunology, significant similarities between the pathogenic antigens contained in a vaccine and human proteins in the person receiving the vaccine can lead to immune “cross-reactivity” and “evolve into an autoimmune process targeting the…self-proteins.”

…studies dating back to the mid-1990s indicate that vaccines, with their unique configuration of viral or bacterial antigens and adjuvants, are a biologically plausible trigger.

Three examples

The Israeli researchers reviewed three examples of probable molecular mimicry, considering the evidence linking the influenza, hepatitis B and human papillomavirus (HPV) vaccines to vaccine-induced autoimmunity.

• Influenza: In 2009, tens of millions of Europeans and North Americans received an H1N1 influenza vaccine containing a novel adjuvant called AS03 (made up of alpha-tocopherol, squalene and polysorbate 80). Soon thereafter, reports began surfacing of sharp increases in two autoimmune conditions, narcolepsy and Guillain-Barre syndrome (GBS)—including a two- to three-fold increased risk of GBS in the 42 days following vaccination. In the case of individuals with narcolepsy, research explaining the development of cross-reactivity and autoimmunity identified a similarity between an influenza vaccine nucleoprotein and a human receptor for the HCRT neurotransmitter (which helps regulate sleep-wake states). Molecular mimicry likewise has been posited as a potential mechanism linking influenza vaccine and GBS.

• Hepatitis B: A number of case reports have suggested a role of hepatitis B virus (HBV) vaccines in the development of autoimmunity, particularly with regard to demyelinating diseases (conditions that damage the protective sheath surrounding nerve fibers in the brain, optic nerves and spinal cord). Demyelinating neuropathies include multiple sclerosis (MS), acute disseminated encephalomyelitis, transverse myelitis and others. A 2005 study established an initial “proof of concept for the theory of molecular mimicry leading to autoimmunity among HBV-vaccinated subjects.” The study looked at similarities between the recombinant (genetically engineered) small HBV surface antigen contained in the HBV vaccine and two human proteins often associated with myelin damage in MS (myelin basic protein and myelin oligodendrocyte glycoprotein) and identified significantly more cross-reactivity in vaccinated subjects versus controls.
  
  
• HPV: Research has suggested a link between HPV vaccination and at least two autoimmune conditions: systemic lupus erythematosus (SLE) and postural orthostatic tachycardia syndrome (POTS)—an abnormal heart rate condition that frequently overlaps with chronic fatigue syndrome. In the case of SLE, the Israeli researchers have called attention in other publications to the “homology” (correspondence) between several of the viral peptides in the vaccine and the human peptides known to be dysregulated in SLE, as well as the molecular mimicry between specific HPV vaccine peptides and human proteins potentially associated with cardiac arrhythmias.

…most vaccine experts ignore the aluminum adjuvants as a potentially significant environmental trigger for autoimmunity.

Autoantibodies in autism

Aluminum adjuvants are present in the majority of vaccines. The Israeli researchers point out that even though aluminum adjuvants are “applied…with the sole purpose of impairing immune tolerance” and potentiating immune response, most vaccine experts ignore the adjuvants as a potentially significant environmental trigger for autoimmunity.

The willingness to overlook aluminum is somewhat surprising in light of other research linking neurotoxic metals—including mercury and lead—to the emergence of brain autoantibodies in children with autism spectrum disorder (ASD). Mercury is still prevalent in many vaccines worldwide and in some vaccines in the U.S. In a study published in 2015, Egyptian investigators described the presence of anti-myelin basic protein (anti-MBP) autoantibodies in autistic children who had elevated blood mercury levels. Characterizing mercury as “one of the main candidate environmental triggers for autoimmunity in autism,” these researchers hypothesized that exposure to “mercury, dietary proteins and microbial antigens” (such as the antigens in vaccines) can launch a chain of autoimmune reactions that begins with molecular mimicry and generation of homologous autoantigens.

Some researchers hypothesize that autoimmune brain pathology (such as is observed in ASD) requires an “event that increases barrier permeability allowing antibodies to traverse blood-brain barrier and gain access to brain tissue to inhibit and alter neuronal processes.” Both mercury and aluminum can damage the blood-brain barrier and enable vaccine antigens to enter the brain.

Taking autoimmunity seriously

Given the proliferation of over 100 autoimmune disorders since the mid-1940s, it is concerning that the three examples presented by the Israeli researchers are, by the authors’ own admission, still subject to “significant debate.” As they go on to explain, there is an unacceptable lack of high-quality scientific data on vaccine-related adverse events. Some of the many reasons why vaccine safety monitoring is flawed include variable diagnostic classification of cases, manipulation of the post-vaccination risk interval, inability to assess underreporting of adverse events (which the U.S. government acknowledges to be widespread), and “substantial publication bias favoring studies that support vaccine safety.” Instead of trying to bury adverse events as inconvenient to the monolithic vaccine safety narrative, we should be paying attention to the “red flags” that adverse reactions clearly represent.

Sign up for free news and updates from Robert F. Kennedy, Jr. and the World Mercury Project. Your donation will help to support us in our efforts.